800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredNo results found!
Medication treatment for opioid use disorder in Milwaukee
Milwaukee is one of the few places in Wisconsin where you can reach nearly every kind of medication treatment for opioid use disorder (OUD) close to home: opioid treatment programs that dispense methadone, office-based prescribers who write buprenorphine, and clinics offering naltrexone. The city and its South Side and North Side neighborhoods carry most of Milwaukee County’s overdose burden, and the county has built out one of the state’s most active harm-reduction responses to match. The clinics listed above serve the Milwaukee area. Use the listings to call a provider directly, or reach the helpline on this page if you want to talk through options first.
Your treatment options and where to get each one
Three medications are approved to treat OUD, and where you get them depends on which one you and a clinician choose. Methadone for OUD is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy, which is why the daily-dosing clinic model exists. Buprenorphine, including Suboxone and other buprenorphine-naloxone products plus the extended-release monthly injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside an OTP. Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but it starts only after you have been off opioids for a set period.
Those two settings, the OTP and office-based opioid treatment (OBOT), are what the listings above represent. Some Milwaukee-area programs offer more than one medication and setting, and telehealth has widened who can start buprenorphine without coming in first. If you are weighing the choice, it helps to read how methadone and Suboxone compare and to look at the clinic-based model before you call, then decide with a provider.
Overdose prevention and harm reduction across Milwaukee County
Milwaukee County has cut overdose deaths sharply for four straight years. The county reported 387 fatal overdoses in 2025, of which 249 involved opioids, a 17.7 percent drop in total overdose deaths and a 22.7 percent drop in opioid deaths from 2024 (Milwaukee County Office of Emergency Management, 2026). Since 2022, when the county recorded 674 overdose deaths, total deaths have fallen roughly 43 percent. County officials credit medication treatment alongside a wide harm-reduction push. Fentanyl remains the driver in most opioid deaths, and it increasingly shows up mixed into cocaine and stimulants, so a supply someone believes is drug-free may not be.
The county’s Harm Reduction MKE initiative stocks vending machines around the community with free naloxone, fentanyl test strips, and medication lock bags, and its “Pull Up & Pick Up” program and a Vivent Health partnership let residents get supplies by pickup or home delivery. The Milwaukee Overdose Response Initiative and fire-department teams follow up with people after an overdose to connect them to care. If you or someone you love uses drugs, carrying naloxone is a reasonable safety step, and a return to use is a common, manageable part of a chronic condition, not a failure. You can learn the warning signs and response in this overdose overview.
Starting treatment and what the first visit looks like
The first step is usually an intake assessment, where a clinician reviews your history and, for methadone or buprenorphine, plans how to begin the medication safely. Bring an ID and any insurance information if you have them, though many programs will still see you if you do not. One thing worth planning: because most of the local drug supply contains fentanyl, starting buprenorphine too soon after using can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician times your first dose carefully. This is a reason to be honest about recent use, not a reason to wait. For a fuller picture of the process, see this guide to methadone treatment when fentanyl is involved and the broader opioid treatment overview.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 (42 CFR Part 8) expanded take-home methadone to as much as a 28-day supply for patients who are stable in treatment, allowed treatment to start by telehealth, authorized mobile medication units, and removed the old requirement that a person have a year of opioid addiction before being admitted. Take-home eligibility is decided by your program based on stability, not by a fixed calendar. As of July 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit; those flexibilities run through the end of 2026 and are still being finalized, so confirm what is current with a provider. Methadone for OUD is still started and dispensed through an OTP. If you are transferring from another program or restarting after a gap, staying on a steady dose matters, and this page on why a consistent methadone dose matters explains why.
Paying for treatment in Wisconsin
Wisconsin’s Medicaid program, BadgerCare Plus, delivered through ForwardHealth, covers all three OUD medications: methadone, buprenorphine products, and naltrexone (Vivitrol). Preferred buprenorphine-naloxone products such as Suboxone are covered without prior authorization, while some non-preferred or buprenorphine-only products still require it (Wisconsin Department of Health Services). Private insurance and Medicare also cover OUD treatment, and Medicare Part B covers OTP services. If you are uninsured, some Milwaukee providers offer sliding-scale fees, and Wisconsin’s Division of Care and Treatment Services administers state and federal grant funding that helps cover care for people who do not qualify for BadgerCare Plus. Ask any program on this page directly what it accepts.
Pregnancy, reentry, and other specific situations
For pregnant patients, staying on or starting methadone or buprenorphine is the recommended standard of care, and treatment is far safer for both parent and baby than continued opioid use; providers manage neonatal opioid withdrawal syndrome (NOWS) after birth. You can read more about methadone and pregnancy. Reentry is a significant local concern: Milwaukee County reporting has tied many overdose deaths among older Black men to prior incarceration in state prisons, where treatment waitlists persist, and the first weeks after release carry a high overdose risk, which makes connecting to medication quickly a priority. Wisconsin jails and some correctional settings now offer medication treatment. Care is confidential, and families can play a real role in helping someone get started; here is information for families.
Naloxone and Wisconsin’s Good Samaritan protections
Naloxone, the medication that reverses an opioid overdose (often sold as Narcan nasal spray), is available over the counter and through pharmacies and community programs. Under Wisconsin’s statewide standing order, pharmacists can dispense it without an individual prescription to anyone at risk or in a position to help someone at risk, and the state distributes it free through many sites, including the county’s harm-reduction vending machines. Wisconsin’s Good Samaritan law provides limited immunity from certain drug-possession charges for a person who calls for help during an overdose, which is meant to make calling 911 the safe choice. Keep more than one dose on hand, since a strong fentanyl overdose can require several.
Common questions about MOUD in Milwaukee
Do I have to go to a clinic every day for methadone?
At first, usually yes. Methadone for OUD is dispensed through an opioid treatment program, and early treatment often means daily visits. As you stabilize, federal rules now allow take-home supplies of up to 28 days, with eligibility decided by your program (SAMHSA, 42 CFR Part 8, 2024).
Can I start Suboxone without going in person?
Often, yes. As of 2026, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit. These rules run through the end of 2026 and are still being finalized, so confirm current options with a provider (DEA; SAMHSA).
Is methadone just trading one drug for another?
No. Methadone and buprenorphine are prescribed, steady-dose medications that reduce cravings and withdrawal without the cycle of illicit use, and long-term medication treatment is legitimate, effective care. You can read more on this common question.
Does BadgerCare Plus cover treatment?
Yes. Wisconsin Medicaid (BadgerCare Plus, through ForwardHealth) covers methadone, buprenorphine products, and naltrexone. Some non-preferred buprenorphine products require prior authorization (Wisconsin Department of Health Services).
What if there is no opening at the clinic I want?
Milwaukee has multiple programs across the city and nearby communities such as West Allis and Wauwatosa, and telehealth can bridge access for buprenorphine. Call more than one listing, and ask each about current openings and how to think about the length of treatment.
Sources and disclosures
Last reviewed July 2026.
Sources:
- Milwaukee County Office of Emergency Management, Overdose Dashboard, and Milwaukee County Executive’s 2025 fatal overdose data release, 2026.
- Milwaukee County Medical Examiner’s Office, overdose death figures, 2025 to 2026.
- Substance Abuse and Mental Health Services Administration (SAMHSA), 42 CFR Part 8 final rule, 2024.
- Drug Enforcement Administration and SAMHSA, telemedicine prescribing flexibilities and buprenorphine telemedicine rule, 2025 to 2026.
- Wisconsin Department of Health Services, BadgerCare Plus and ForwardHealth MOUD coverage, statewide naloxone standing order, and Good Samaritan guidance.
- U.S. Food and Drug Administration (FDA), approved medications for opioid use disorder.
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. MethadoneCenters.com is not owned or operated by any treatment facility. MethadoneCenters.com does not endorse any treatment facility or guarantee the quality of care provided, or the results to be achieved, by any treatment facility. The information provided by MethadoneCenters.com is not a substitute for professional treatment advice.
Calls to any general helpline will be answered or returned by a paid advertiser. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.